The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...
CNTY-813, lead beta islet cell therapy program as a potential functional cure for type 1 diabetes, in Investigational New Drug (IND)-enabling studies; IND submission expected in 4Q 2026 to support ...
Computer scientists and weather scientists have taken the first steps toward creating an AI agent capable of analyzing and ...
Detailed price information for Day One Biopharmaceuticals Inc (DAWN-Q) from The Globe and Mail including charting and trades.
Computer scientists and weather scientists have taken the first steps toward creating an AI agent capable of analyzing and ...
Amjad Masad announced that Replit has raised $400 million in a Series D, and also unveiled a powerful new agent.
LILONGWE-(MaraviPost)-In Malawi’s public institutions, leadership appointments have often come and gone with little more than a murmur from the public yet the recent appointment of Brian Banda as ...
When a worker thread completes a task, it doesn't return a sprawling transcript of every failed attempt; it returns a compressed summary of the successful tool calls and conclusions.
As artificial intelligence (AI) becomes more common in health care, from managing records to assisting with medication decisions, researchers at the Icahn School of Medicine at Mount Sinai are asking ...
Mount Sinai study multi-agent AI shows higher accuracy and lower computing use managing up to 80 clinical tasks simultaneously in simulations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results